Developing new influenza vaccines for better protection against the flu
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center
This study is looking for ways to make better flu vaccines that can protect you for a longer time and against different types of the flu, and if you join, you could help test these new vaccines to see how well they work and if they're safe for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11042079 on NIH RePORTER |
What this research studies
This research focuses on creating and testing innovative influenza vaccine candidates and delivery methods to provide long-lasting and broad protection against various strains of the flu virus. The approach includes analyzing immune responses to guide vaccine design, conducting laboratory tests to assess vaccine effectiveness, and performing clinical trials to evaluate safety and efficacy in humans. Patients may have the opportunity to participate in these trials, contributing to the development of more effective flu vaccines.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who are at higher risk for influenza complications, such as the elderly, young children, and those with underlying health conditions.
Not a fit: Patients who are not at risk for influenza or those who have already received a flu vaccine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective influenza vaccines that provide better protection against multiple strains of the virus.
How similar studies have performed: Previous research has shown promise in developing innovative vaccine strategies, indicating potential for success in this area.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Krammer, Florian — Icahn School of Medicine at Mount Sinai
- Study coordinator: Krammer, Florian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.